首页> 美国卫生研究院文献>Ancient Science of Life >ROLE OF PUSHKARA GUGGULU IN THE MANAGEMENT OF ISCHAEMIC HEART DISEASE
【2h】

ROLE OF PUSHKARA GUGGULU IN THE MANAGEMENT OF ISCHAEMIC HEART DISEASE

机译:假单胞菌在缺血性心脏病治疗中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

On the basis of authentic references from the literature of ayurveda and on our own observations, Puskara-Guggulu, a combination of oleoresin of C. mukul and I-recemosa, has been clinically tried on a series of ECG proved 50 patients of ischaemic heart disease. This has been administered in the dose of 6 gms per day, in three divided doses upto a period of four months. Precordial pain, discomfort and dyspnoea on effort have been controlled. Mean Serum cholesterol has been found to be decreased by 17.47%. Apart from that, marked improved in the E. C. G. pattern in 30% cases has been recorded in terms of ST-segment and T wave changes, On the whole the result was cured 10% relieved 60%, improved 20% and unchanged 10%, offering a great hope for the prevention and cure of ischaemic heart disease
机译:根据阿育吠陀文献的真实参考以及我们的观察,对C. mukul的油树脂和I-recemosa的组合Puskara-Guggulu进行了一系列ECG临床试验,证明有50例缺血性心脏病。每天以6克的剂量服用,分三个剂量服用,持续四个月。心前区疼痛,不适和呼吸困难已得到控制。已发现平均血清胆固醇降低了17.47%。除此之外,在ST段和T波变化方面,记录到30%病例的ECG模式有显着改善,结果总体上治愈了10%,缓解了60%,改善了20%,未改变10%,提供了预防和治疗缺血性心脏病的巨大希望

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号